期刊文献+

慢性粒细胞白血病患者FcεRⅠγ链基因表达上调 被引量:1

Overexpression of FcεRⅠγ gene in patients with CML
下载PDF
导出
摘要 目的:在慢性粒细胞白血病病人(CML),CD3ζ链表达明显下降,分析与CD3ζ存在互补关系的FcεRⅠγ基因在CML患者中表达水平,以了解T细胞免疫中TCR信号转导的变化情况。方法:利用SYBR GreenⅠ实时荧光定量RT-PCR法测定CML患者和健康人各20例的外周血单个核细胞(PBMCs)的FcεRⅠγ基因表达水平,以β2微球蛋白基因(β2MG)作为内参照,采用相对定量公式:2-ΔCt×100%,计算FcεRⅠγ链的相对mRNA表达量。结果:CML患者PBMCs中FcεRⅠγ基因表达水平明显高于健康对照组(P<0.001)。FcεRⅠγ表达水平变化与病人外周血CD3+T细胞比例无相关性。结论:CML病人中FcεRⅠγ表达上升,提示FcεRⅠγ可能在一定程度调节CD3ζ链缺陷所带来的T细胞免疫异常。 Aim:In order to understand the change of TCR signal transduction in T-cell immunization,the expression level of FcεRⅠγ chain gene,which is complementary with the CD3ζ,was analyzed,based on the down expression of CD3ζ chain gene in patients with chronic myelocytic leukemia(CML).Methods: Real-time PCR with SYBR GreenⅠ technology was used to determine the expression level of FcεRⅠγ chain in peripheral blood mononuclear cells(PBMCs)from 20 patients with CML and 20 healthy individuals.β2-microglobulin gene(β2M) was used as an endogenous reference.Relative changes in FcεRⅠγ gene expression level were determined by the 2-△Ct method between patients with CML and normal individuals.Results: The results showed that the expression levels of FcεRⅠγ gene in PBMCs from CML patients were higher than that from healthy individuals(P 0.001).However,the expression levels of FcεRⅠγ gene had no correlation with the percentage of CD3+ T cell in PBMCs.Conclusion:Overexpression of FcεRⅠγ gene might partially overcome the abnormal T-cell immune state due to the deficiency of CD3ζ gene in patients with CML.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2011年第4期379-382,共4页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省自然科学基金重点项目(9251063201000001)
关键词 慢性粒细胞性白血病 FcεRⅠγ CD3ζ 基因表达 实时荧光定量RT-PCR chronic myelocytic leukemia FcεRⅠγ CD3ζ gene expression real-time PCR
  • 相关文献

参考文献12

  • 1LI Y, GENG S, YIN Q, et al. Decreased level of recent thymic emigrants in CD4 + and CD8 + T cells from CML patients[J]. J Transl Med, 2010 May 14,8: 47.
  • 2杨力建,陈少华,王亮,陈思,郁志,卢育洪,李扬秋.CML病人外周血T细胞CD3基因表达模式变化[J].中国实验血液学杂志,2010,18(4):937-941. 被引量:3
  • 3LEEANSYAH E, WINES B D, CROWE S M,et al. The mechanism underlying defective fc-receptor mediated phagocytosis by HIV-1-Infected human monocyte derived macrophages [ J ]. J Immunol, 2007, 178 (2) : 1096 - 1104.
  • 4CHEN X, WOICIECHOWSKY A, RAFFEGERST S, et al. Impaired expression of the CD3-zeta chain in periph- eral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis [ J ]. Br J Haematol, 2000, 111 (3) : 817 -825.
  • 5SUCHULE J, BERGKVIST L, HAKANSSON L, et al. Down regulation of the CD3-zeta chain in sentinel node biopsies from breast cancer patients [ J ]. Breast Cancer Res Treat, 2002, 74 ( 1 ) : 33 - 40.
  • 6KUSS I, RABINOWLCH H, GOODING W, et al. Expression of zeta in T cells prior to inter-leukin therapy as a predictor of response and survival in patients with ovarian carcinoma[ J]. Cancer Biother Radiopharm, 2002, 17 ( 6 ):631-640.
  • 7MAKI A, MATSUDA M, ASAKAWA M, et al. Decreased CD3 zeta molecules of T lympho-cytes from patientswith hepato2 cellular carcinoma associated with hepatitis C virus [ J ]. Hepatol Res, 2003, 27 (4) : 272 - 278.
  • 8SHIBUYA T Y, NUGYEN N, MCLAREN C E, et al. Clinical significance of poor CD3 response in head and neck cancer[J]. Clin Cancer Res, 2002, 8 (3) : 745 - 751.
  • 9FRYDECKA I, BOCKO D, KOSMACZEWSKA A, et al. The effect of peripheral blood lymp-hocyte stim-ulation on zeta chain expression and IL-2 production in Hodgkinps disease[J]. Br J Cancer, 2001, 84 (10): 1339- 1343.
  • 10KOYASU S, D'ADAMIO L, ARULANANDAM A R, et al. T cell receptor complexes contai-ning Fc epsilon RI gamma homodimers in lieu of CD3 zata and CD3 eta components: a novel isoform expressed on large granular lymphocytes[ J]. J Exp Med, 1992, 1,175 : 203 - 209.

二级参考文献16

  • 1耿素霞,李扬秋,陈少华,杨力建,尹青松,吴秀丽,张学利.慢性粒细胞白血病患者外周血初始T细胞水平和T细胞受体Vβ谱系利用特点[J].中华血液学杂志,2005,26(7):413-416. 被引量:10
  • 2Shores EW, Love PE. TCR zeta chain in T cell development and selection. Curt Opin Immunol, 1997; 9(3) :380 -389.
  • 3Dadi HK, Simon AJ, Roifman CM. Effect of CD3deha deficiency on maturation of alpha/beta and gamma/deha T-cell lineages in severe combinaed i,nmunodifeiciency. N Engl J Med, 2003 ; 349 ( 19 ) : 1821 - 1828.
  • 4Roifman CM, CD3 delta immunodeficiency. Curr Opin Allergy Clin Immunol, 2004; 4(6) :479 -484.
  • 5Li Y. Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Hematology, 2008 ; 13(5) :267 -275.
  • 6Chen S, Yang L, Chen S, et al. TCR zeta chain expression in T cells from patients with CML. Hematology, 2009; 14(2) :95 -100.
  • 7Stams WA, den Boer ML, Beverloo HB, et al. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t ( 12 ; 21 )^+ pediatric ALL. Blood, 2003 ; 101 ( 7 ) : 2743 - 2747.
  • 8Call ME, Wucherpfenning KW. The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol, 2005 ; 23 (12) : 101 - 125.
  • 9Call ME, Pyrdol J, Wucherpfenning KW. Stoichiometry of the T-cell receptor-CD3 complex and key intermediates assembled in the endoplasmic reticulum. EMBO J, 2004; 23(12) :2348 -2357.
  • 10Chitu V, Fajka-Boja R, Toth GK, et al. Comparative study on the effect of phosphorylated TCR zeta chain ITAM sequences on early activation events in Jurkat T cells. Peptides, 2001; 22 (12) :1963 - 1971.

共引文献2

同被引文献14

  • 1Chen S, Zha X, Yang L, et al. Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients[J]. Hematology, 2011, 16(6): 31-36.
  • 2Leeansyah E, Winesb D, Crowes M, et al. The mechanism underlying defective fc-receptor mediated phagocytosis by HIV-l-Infected human monocyte derived macrophages[J]. J Immunol, 2007, 178(2): 1096 -1104.
  • 3Stamatopoulos B, Haibe Kains B, Equeter C, et al. Gene expression profiling reveals differences in microenviron- ment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA [J]. Haematologica, 2009, 94(6): 790-799.
  • 4Li Y, Yin Q, Yang L, et al. Reduced levels of recent thymic emigrants in acute myeloid leukemia patients [J]. Cancer Immunol Immunother, 2009, 58(7): 1047-1055.
  • 5Li Y, Chen S, Yang L, et al. Clonal expanded TCR V T ceils in patients with APL[J]. Hematology, 2005, 10(2): 135-139.
  • 6Rellahan BL, Jensen JP, Howcroft TK, et al. Elf-1 regulates basal expression from the T cell antigen receptorS-chain gene promoter[J]. J Immunol, 1998, 160(6):2794-2801.
  • 7Kulkarni DP, Wadia PP, Pradhan TN, et al. Mechanisms involved in the down-regulation of TCR zeta chain in tumor versus peripheral blood of oral cancer patients [J]. Int J Cancer, 2009, 124(7): 1605-1613.
  • 8De Paola F, Ridolfi R, Riccobon A, et al. Restored T-ell activation mechanisms in human tumour -infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2 [J]. Br J Cancer, 2003, 88 (2): 320-326.
  • 9Juang YT, Tenbrock K, Nambiar MP, et al. Defective production of functional 98-kD form of Elf-1 is responsible for the decreased exp ression of TCR zeta - chain in patients with systemic lupus erythematosus[J]. J Immunol, 2002, 169 (10):6048-6055.
  • 10Juang YT, Sumibcay L, Tolnay M, et al. Elf-1 binds to GGAA elements on the FcRgamma promoter and represses its expression[J]. J Immunol, 2007, 179(7): 4884--4889.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部